microRNA information: hsa-miR-128-3p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-128-3p | miRbase |
| Accession: | MIMAT0000424 | miRbase |
| Precursor name: | hsa-mir-128-1 | miRbase |
| Precursor accession: | MI0000447 | miRbase |
| Symbol: | MIR128-1 | HGNC |
| RefSeq ID: | NR_029672 | GenBank |
| Sequence: | UCACAGUGAACCGGUCUCUUU |
Reported expression in cancers: hsa-miR-128-3p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-128-3p | bladder cancer | upregulation | "Overexpression of miR-128 inhibited cell prolifera ......" | 26722309 | |
| hsa-miR-128-3p | breast cancer | upregulation | "miR-128 is more highly expressed in drug-resistant ......" | 23526655 | |
| hsa-miR-128-3p | colorectal cancer | downregulation | "miR-128 has been reported to be deregulated in dif ......" | 26352220 | qPCR |
| hsa-miR-128-3p | gastric cancer | deregulation | "We compared mRNA and miRNA expression levels among ......" | 26334097 | Reverse transcription PCR; qPCR |
| hsa-miR-128-3p | glioblastoma | upregulation | "Here we demonstrate for the first time that platel ......" | 22922228 | |
| hsa-miR-128-3p | glioblastoma | upregulation | "To functionally validate the profiling results sug ......" | 27063952 | |
| hsa-miR-128-3p | head and neck cancer | upregulation | "The expression levels of miR-128 and its targeted ......" | 25764126 | qPCR |
| hsa-miR-128-3p | liver cancer | downregulation | "microRNAs miRNAs are known to be involved in the p ......" | 25962360 | qPCR |
| hsa-miR-128-3p | liver cancer | downregulation | "Dysregulation of miRNAs is a common feature in hum ......" | 26550456 | |
| hsa-miR-128-3p | lung cancer | deregulation | "Mechanically we showed significant down-regulation ......" | 27690301 | |
| hsa-miR-128-3p | lung squamous cell cancer | downregulation | "In this study we showed that the expression level ......" | 25001183 | |
| hsa-miR-128-3p | prostate cancer | upregulation | "The inhibition of Bmi-1 by NVP-LDE-225 was regulat ......" | 23567619 | |
| hsa-miR-128-3p | prostate cancer | downregulation | "The aim of this study was to evaluate the prognost ......" | 26339409 | Reverse transcription PCR |
Reported cancer pathway affected by hsa-miR-128-3p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-128-3p | acute myeloid leukemia | cell cycle pathway; Apoptosis pathway | "Effect of miR 128 in DNA damage of HL 60 acute mye ......" | 24846063 | Western blot |
| hsa-miR-128-3p | bladder cancer | Apoptosis pathway | "miR 128 downregulation promotes growth and metasta ......" | 26722309 | |
| hsa-miR-128-3p | breast cancer | Apoptosis pathway | "Reduced miR 128 in breast tumor initiating cells i ......" | 21953503 | |
| hsa-miR-128-3p | colorectal cancer | cell cycle pathway | "In particular we examined miR-128 expression which ......" | 24046120 | |
| hsa-miR-128-3p | colorectal cancer | Apoptosis pathway; PI3K/Akt signaling pathway | "miR-128 has been reported to be deregulated in dif ......" | 26352220 | Western blot; Colony formation; Luciferase |
| hsa-miR-128-3p | glioblastoma | Epithelial mesenchymal transition pathway | "NPV LDE 225 Erismodegib inhibits epithelial mesenc ......" | 23482671 | Luciferase; Western blot |
| hsa-miR-128-3p | liver cancer | cell cycle pathway | "To investigate the expression of microRNA-128a miR ......" | 25345933 | MTT assay; Luciferase; Western blot |
| hsa-miR-128-3p | lung cancer | PI3K/Akt signaling pathway | "Here we show that miR-128 directly targets PFK liv ......" | 27186417 | Colony formation |
| hsa-miR-128-3p | lung cancer | Apoptosis pathway | "MiR 128 reverses the gefitinib resistance of the l ......" | 27690301 | |
| hsa-miR-128-3p | lung squamous cell cancer | Apoptosis pathway | "In this study we showed that the expression level ......" | 25001183 | Colony formation; Luciferase |
| hsa-miR-128-3p | ovarian cancer | cell cycle pathway | "In an initial effort to systematically address thi ......" | 22853714 | |
| hsa-miR-128-3p | sarcoma | PI3K/Akt signaling pathway | "In the present study we found that miR-128 express ......" | 24132591 |
Reported cancer prognosis affected by hsa-miR-128-3p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-128-3p | acute myeloid leukemia | drug resistance | "Effect of miR 128 in DNA damage of HL 60 acute mye ......" | 24846063 | Western blot |
| hsa-miR-128-3p | bladder cancer | metastasis; differentiation | "miR 128 downregulation promotes growth and metasta ......" | 26722309 | |
| hsa-miR-128-3p | breast cancer | drug resistance; poor survival | "Reduced miR 128 in breast tumor initiating cells i ......" | 21953503 | |
| hsa-miR-128-3p | breast cancer | drug resistance | "Specifically we will discuss key miRNAs involved i ......" | 27721895 | |
| hsa-miR-128-3p | colorectal cancer | recurrence | "In particular we examined miR-128 expression which ......" | 24046120 | |
| hsa-miR-128-3p | colorectal cancer | staging; metastasis | "miR-128 has been reported to be deregulated in dif ......" | 26352220 | Western blot; Colony formation; Luciferase |
| hsa-miR-128-3p | endometrial cancer | malignant trasformation | "Expression profiling of normal and malignant endom ......" | 20028871 | |
| hsa-miR-128-3p | glioblastoma | malignant trasformation | "In our study we examined by microarray the global ......" | 16039986 | |
| hsa-miR-128-3p | glioblastoma | progression | "Here we demonstrate for the first time that platel ......" | 22922228 | |
| hsa-miR-128-3p | glioblastoma | differentiation | "Interestingly we observed that several identified ......" | 24465609 | |
| hsa-miR-128-3p | liver cancer | worse prognosis; poor survival; progression | "miR 128 3p suppresses hepatocellular carcinoma pro ......" | 25962360 | Western blot |
| hsa-miR-128-3p | liver cancer | metastasis; tumorigenesis | "miR 128 modulates hepatocellular carcinoma by inhi ......" | 26550456 | |
| hsa-miR-128-3p | lung cancer | poor survival | "Here we show that miR-128 directly targets PFK liv ......" | 27186417 | Colony formation |
| hsa-miR-128-3p | lung cancer | drug resistance | "MiR 128 reverses the gefitinib resistance of the l ......" | 27690301 | |
| hsa-miR-128-3p | lung squamous cell cancer | staging | "We assessed by quantitative reverse transcription ......" | 24448358 | |
| hsa-miR-128-3p | lung squamous cell cancer | staging; metastasis; differentiation; progression | "In this study we showed that the expression level ......" | 25001183 | Colony formation; Luciferase |
| hsa-miR-128-3p | lung squamous cell cancer | tumor size | "Here we analyzed expression of miR-15a/16 miR-21 m ......" | 25384507 | |
| hsa-miR-128-3p | ovarian cancer | motility | "Regulation of colony stimulating factor 1 expressi ......" | 22909061 | |
| hsa-miR-128-3p | ovarian cancer | drug resistance | "Deregulation of miR 128 in ovarian cancer promotes ......" | 25248111 | |
| hsa-miR-128-3p | prostate cancer | progression | "Quantitative proteomic profiling of prostate cance ......" | 19955085 | |
| hsa-miR-128-3p | prostate cancer | progression | "miR 128 modulates chemosensitivity and invasion of ......" | 25921099 | Western blot; Luciferase; Transwell assay |
| hsa-miR-128-3p | prostate cancer | malignant trasformation; staging; metastasis; poor survival; recurrence; progression; worse prognosis | "MicroRNA-128 miR-128 has been identified as a nega ......" | 26339409 |
Reported gene related to hsa-miR-128-3p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-128-3p | breast cancer | ABCC5 | "Reduced miR 128 in breast tumor initiating cells i ......" | 21953503 |
| hsa-miR-128-3p | ovarian cancer | ABCC5 | "Overexpression of miR-128 resensitized SKOV3/CP ce ......" | 25248111 |
| hsa-miR-128-3p | breast cancer | SNAI1 | "Namely miR-128 suppression realized after AurkA bi ......" | 27341528 |
| hsa-miR-128-3p | prostate cancer | SNAI1 | "Loss of SNAIL inhibits cellular growth and metabol ......" | 24859886 |
| hsa-miR-128-3p | bladder cancer | VEGFC | "miR 128 downregulation promotes growth and metasta ......" | 26722309 |
| hsa-miR-128-3p | lung squamous cell cancer | VEGFC | "Interestingly ectopic miR-128 overexpression could ......" | 25001183 |
| hsa-miR-128-3p | lung cancer | ATP8A2 | "In line with this overexpression of miR-128 decrea ......" | 27186417 |
| hsa-miR-128-3p | breast cancer | AURKA | "AurkA controls self renewal of breast cancer initi ......" | 27341528 |
| hsa-miR-128-3p | breast cancer | BAX | "We have confirmed that Bax is the target of miR-12 ......" | 23526655 |
| hsa-miR-128-3p | acute myeloid leukemia | BECN1 | "Overexpression of miR-128 increased programmed cel ......" | 24846063 |
| hsa-miR-128-3p | glioblastoma | BMI1 | "The inhibition of Bmi1 by NPV-LDE-225 was regulate ......" | 23482671 |
| hsa-miR-128-3p | ovarian cancer | CSF1 | "By mutations in putative miRNA targets in CSF-1 mR ......" | 22909061 |
| hsa-miR-128-3p | ovarian cancer | CSF2 | "Regulation of colony stimulating factor 1 expressi ......" | 22909061 |
| hsa-miR-128-3p | liver cancer | CYP2C9 | "To investigate the molecular mechanisms that contr ......" | 25704921 |
| hsa-miR-128-3p | colorectal cancer | INSR | "In addition insulin receptor substrate 1 IRS1 a k ......" | 26352220 |
| hsa-miR-128-3p | colorectal cancer | IRS1 | "In addition insulin receptor substrate 1 IRS1 a k ......" | 26352220 |
| hsa-miR-128-3p | liver cancer | ITGA2 | "miR 128 modulates hepatocellular carcinoma by inhi ......" | 26550456 |
| hsa-miR-128-3p | liver cancer | ITGA5 | "miR 128 modulates hepatocellular carcinoma by inhi ......" | 26550456 |
| hsa-miR-128-3p | lung cancer | MET | "In addition the gene of c-met was proved to be dir ......" | 27690301 |
| hsa-miR-128-3p | colorectal cancer | NEK2 | "In particular we examined miR-128 expression which ......" | 24046120 |
| hsa-miR-128-3p | lung cancer | PFKL | "Here we show that miR-128 directly targets PFK liv ......" | 27186417 |
| hsa-miR-128-3p | acute myeloid leukemia | PIK3C3 | "Overexpression of miR-128 increased programmed cel ......" | 24846063 |
| hsa-miR-128-3p | liver cancer | PIK3CD | "Mechanistically miR-128-3p was confirmed to regula ......" | 25962360 |
| hsa-miR-128-3p | liver cancer | PIK3R1 | "miR 128 3p suppresses hepatocellular carcinoma pro ......" | 25962360 |
| hsa-miR-128-3p | sarcoma | PTEN | "At the molecular level our results demonstrated th ......" | 24132591 |
| hsa-miR-128-3p | glioblastoma | RAP1B | "miR 128 and miR 149 enhance the chemosensitivity o ......" | 25017996 |
| hsa-miR-128-3p | prostate cancer | RPS6KB1 | "Luciferase reporter assays showed the SNAIL regula ......" | 24859886 |
| hsa-miR-128-3p | breast cancer | TGFB1 | "The role of microRNA 128a in regulating TGFbeta si ......" | 20054641 |
| hsa-miR-128-3p | acute myeloid leukemia | TP53BP1 | "In addition miR-128 overexpression increased the l ......" | 24846063 |
| hsa-miR-128-3p | bladder cancer | VEGFA | "miR 128 downregulation promotes growth and metasta ......" | 26722309 |
| hsa-miR-128-3p | breast cancer | WNT3A | "AurkA controls self renewal of breast cancer initi ......" | 27341528 |
| hsa-miR-128-3p | prostate cancer | ZEB1 | "miR 128 modulates chemosensitivity and invasion of ......" | 25921099 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-128-3p | A2M | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LGG; LUAD; LUSC; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.74; TCGA BRCA -0.212; TCGA CESC -0.26; TCGA COAD -0.647; TCGA ESCA -0.584; TCGA KIRP -0.288; TCGA LGG -0.173; TCGA LUAD -0.541; TCGA LUSC -0.75; TCGA SARC -0.62; TCGA STAD -0.627; TCGA UCEC -0.347 |
hsa-miR-128-3p | AFF4 | 10 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; STAD; UCEC | miRNAWalker2 validate; MirTarget | TCGA BLCA -0.112; TCGA BRCA -0.256; TCGA COAD -0.168; TCGA ESCA -0.261; TCGA KIRC -0.107; TCGA LIHC -0.106; TCGA LUAD -0.102; TCGA LUSC -0.098; TCGA STAD -0.188; TCGA UCEC -0.08 |
hsa-miR-128-3p | ARID5B | 10 cancers: BLCA; BRCA; COAD; ESCA; LUAD; LUSC; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.356; TCGA BRCA -0.358; TCGA COAD -0.128; TCGA ESCA -0.248; TCGA LUAD -0.1; TCGA LUSC -0.084; TCGA SARC -0.2; TCGA THCA -0.323; TCGA STAD -0.129; TCGA UCEC -0.213 |
hsa-miR-128-3p | BMPR2 | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LUAD; LUSC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.156; TCGA BRCA -0.22; TCGA COAD -0.366; TCGA ESCA -0.225; TCGA KIRC -0.141; TCGA LUAD -0.158; TCGA LUSC -0.195; TCGA STAD -0.094; TCGA UCEC -0.132 |
hsa-miR-128-3p | BOC | 10 cancers: BLCA; BRCA; COAD; ESCA; LGG; LIHC; LUAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.864; TCGA BRCA -0.296; TCGA COAD -1.1; TCGA ESCA -0.883; TCGA LGG -0.134; TCGA LIHC -0.168; TCGA LUAD -0.288; TCGA PRAD -0.215; TCGA STAD -1.335; TCGA UCEC -0.297 |
hsa-miR-128-3p | CASQ2 | 12 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -1.963; TCGA BRCA -0.843; TCGA COAD -2.233; TCGA ESCA -1.785; TCGA KIRC -0.404; TCGA KIRP -0.363; TCGA LUAD -0.879; TCGA LUSC -0.626; TCGA PRAD -0.263; TCGA SARC -1.413; TCGA STAD -2.316; TCGA UCEC -0.725 |
hsa-miR-128-3p | CCL17 | 11 cancers: BLCA; CESC; COAD; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.248; TCGA CESC -0.426; TCGA COAD -0.435; TCGA LUAD -0.994; TCGA LUSC -0.761; TCGA OV -0.409; TCGA PAAD -0.743; TCGA SARC -0.597; TCGA THCA -1.668; TCGA STAD -0.536; TCGA UCEC -0.254 |
hsa-miR-128-3p | CDH5 | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LGG; LIHC; LUAD; LUSC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.263; TCGA BRCA -0.385; TCGA COAD -0.443; TCGA ESCA -0.235; TCGA KIRP -0.342; TCGA LGG -0.095; TCGA LIHC -0.176; TCGA LUAD -0.336; TCGA LUSC -0.595; TCGA STAD -0.176; TCGA UCEC -0.358 |
hsa-miR-128-3p | CLDN5 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LGG; LUAD; LUSC; OV; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.563; TCGA BRCA -0.549; TCGA CESC -0.273; TCGA COAD -0.815; TCGA ESCA -0.341; TCGA KIRP -0.45; TCGA LGG -0.087; TCGA LUAD -0.438; TCGA LUSC -0.598; TCGA OV -0.215; TCGA PRAD -0.178; TCGA STAD -0.864; TCGA UCEC -0.533 |
hsa-miR-128-3p | CPEB4 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.284; TCGA BRCA -0.357; TCGA CESC -0.278; TCGA COAD -0.235; TCGA ESCA -0.36; TCGA KIRC -0.2; TCGA LIHC -0.213; TCGA LUAD -0.229; TCGA LUSC -0.354; TCGA SARC -0.4; TCGA STAD -0.265; TCGA UCEC -0.257 |
hsa-miR-128-3p | EFEMP2 | 14 cancers: BLCA; BRCA; COAD; ESCA; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.408; TCGA BRCA -0.207; TCGA COAD -0.643; TCGA ESCA -0.349; TCGA LGG -0.144; TCGA LIHC -0.283; TCGA LUAD -0.274; TCGA LUSC -0.469; TCGA OV -0.137; TCGA PAAD -0.633; TCGA PRAD -0.327; TCGA SARC -0.162; TCGA STAD -0.614; TCGA UCEC -0.226 |
hsa-miR-128-3p | EGFR | 9 cancers: BLCA; BRCA; CESC; COAD; LGG; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate; miRTarBase | TCGA BLCA -0.203; TCGA BRCA -0.404; TCGA CESC -0.325; TCGA COAD -0.164; TCGA LGG -0.123; TCGA PAAD -0.55; TCGA THCA -0.411; TCGA STAD -0.518; TCGA UCEC -0.394 |
hsa-miR-128-3p | ETF1 | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LIHC; PRAD; SARC | miRNAWalker2 validate | TCGA BLCA -0.144; TCGA BRCA -0.074; TCGA CESC -0.088; TCGA HNSC -0.066; TCGA KIRC -0.077; TCGA KIRP -0.066; TCGA LIHC -0.075; TCGA PRAD -0.076; TCGA SARC -0.113 |
hsa-miR-128-3p | EYA4 | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LUSC; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.523; TCGA BRCA -0.647; TCGA COAD -0.706; TCGA ESCA -0.496; TCGA KIRC -0.678; TCGA KIRP -0.776; TCGA LUSC -0.421; TCGA PRAD -0.636; TCGA STAD -0.372 |
hsa-miR-128-3p | FNBP1 | 9 cancers: BLCA; COAD; ESCA; KIRP; LUSC; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.375; TCGA COAD -0.598; TCGA ESCA -0.469; TCGA KIRP -0.152; TCGA LUSC -0.143; TCGA SARC -0.434; TCGA THCA -0.092; TCGA STAD -0.775; TCGA UCEC -0.214 |
hsa-miR-128-3p | GAS7 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LUAD; LUSC; OV; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.917; TCGA BRCA -0.405; TCGA CESC -0.501; TCGA COAD -0.738; TCGA ESCA -0.746; TCGA KIRP -0.298; TCGA LUAD -0.398; TCGA LUSC -0.623; TCGA OV -0.15; TCGA THCA -0.283; TCGA STAD -0.68; TCGA UCEC -0.307 |
hsa-miR-128-3p | GFPT2 | 15 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -1.11; TCGA CESC -0.626; TCGA COAD -0.945; TCGA ESCA -0.909; TCGA HNSC -0.193; TCGA KIRC -0.525; TCGA KIRP -0.214; TCGA LGG -0.108; TCGA LIHC -0.672; TCGA LUSC -0.713; TCGA PAAD -0.694; TCGA PRAD -0.202; TCGA THCA -0.557; TCGA STAD -0.599; TCGA UCEC -0.497 |
hsa-miR-128-3p | GNAQ | 9 cancers: BLCA; BRCA; ESCA; KIRC; LUAD; LUSC; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.159; TCGA BRCA -0.258; TCGA ESCA -0.208; TCGA KIRC -0.102; TCGA LUAD -0.187; TCGA LUSC -0.183; TCGA SARC -0.133; TCGA STAD -0.286; TCGA UCEC -0.188 |
hsa-miR-128-3p | GNB5 | 9 cancers: BLCA; BRCA; COAD; HNSC; KIRC; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.213; TCGA BRCA -0.114; TCGA COAD -0.276; TCGA HNSC -0.119; TCGA KIRC -0.092; TCGA SARC -0.203; TCGA THCA -0.176; TCGA STAD -0.16; TCGA UCEC -0.23 |
hsa-miR-128-3p | HEY2 | 9 cancers: BLCA; BRCA; COAD; LGG; LUAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.227; TCGA BRCA -0.219; TCGA COAD -0.403; TCGA LGG -0.071; TCGA LUAD -0.206; TCGA SARC -0.365; TCGA THCA -0.347; TCGA STAD -0.155; TCGA UCEC -0.178 |
hsa-miR-128-3p | HRASLS5 | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LUAD; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.785; TCGA BRCA -0.95; TCGA COAD -0.845; TCGA ESCA -0.559; TCGA KIRC -0.454; TCGA LUAD -0.359; TCGA PAAD -0.586; TCGA PRAD -0.776; TCGA THCA -0.481; TCGA STAD -0.822; TCGA UCEC -0.371 |
hsa-miR-128-3p | ITPR1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.365; TCGA BRCA -0.66; TCGA CESC -0.228; TCGA COAD -0.661; TCGA ESCA -0.758; TCGA KIRC -0.357; TCGA KIRP -0.305; TCGA LUAD -0.287; TCGA LUSC -0.343; TCGA PRAD -0.399; TCGA SARC -0.631; TCGA STAD -0.726; TCGA UCEC -0.546 |
hsa-miR-128-3p | JAK1 | 11 cancers: BLCA; BRCA; CESC; ESCA; LIHC; LUAD; LUSC; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.235; TCGA BRCA -0.207; TCGA CESC -0.09; TCGA ESCA -0.167; TCGA LIHC -0.109; TCGA LUAD -0.159; TCGA LUSC -0.209; TCGA SARC -0.083; TCGA THCA -0.207; TCGA STAD -0.092; TCGA UCEC -0.146 |
hsa-miR-128-3p | KLF4 | 9 cancers: BLCA; BRCA; HNSC; LIHC; LUAD; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate; MirTarget | TCGA BLCA -0.355; TCGA BRCA -0.527; TCGA HNSC -0.168; TCGA LIHC -0.598; TCGA LUAD -0.236; TCGA PAAD -0.384; TCGA PRAD -0.189; TCGA STAD -0.346; TCGA UCEC -0.414 |
hsa-miR-128-3p | LDLR | 13 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.174; TCGA BRCA -0.133; TCGA ESCA -0.166; TCGA KIRC -0.446; TCGA KIRP -0.384; TCGA LIHC -0.316; TCGA LUAD -0.311; TCGA LUSC -0.125; TCGA PAAD -0.666; TCGA PRAD -0.153; TCGA SARC -0.397; TCGA THCA -0.869; TCGA UCEC -0.193 |
hsa-miR-128-3p | LIFR | 9 cancers: BLCA; BRCA; COAD; ESCA; LIHC; LUAD; LUSC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.328; TCGA BRCA -0.607; TCGA COAD -1.085; TCGA ESCA -0.688; TCGA LIHC -0.378; TCGA LUAD -0.198; TCGA LUSC -0.348; TCGA STAD -0.665; TCGA UCEC -0.481 |
hsa-miR-128-3p | LILRB5 | 9 cancers: BLCA; ESCA; LGG; LIHC; LUAD; LUSC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.635; TCGA ESCA -0.69; TCGA LGG -0.171; TCGA LIHC -0.28; TCGA LUAD -0.312; TCGA LUSC -0.718; TCGA THCA -0.252; TCGA STAD -0.455; TCGA UCEC -0.279 |
hsa-miR-128-3p | LITAF | 15 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.303; TCGA BRCA -0.083; TCGA CESC -0.127; TCGA COAD -0.116; TCGA HNSC -0.073; TCGA KIRC -0.249; TCGA KIRP -0.111; TCGA LGG -0.078; TCGA LIHC -0.251; TCGA LUSC -0.332; TCGA PAAD -0.347; TCGA PRAD -0.1; TCGA THCA -0.179; TCGA STAD -0.127; TCGA UCEC -0.215 |
hsa-miR-128-3p | LYSMD3 | 9 cancers: BLCA; BRCA; ESCA; LGG; LIHC; LUAD; LUSC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.136; TCGA BRCA -0.239; TCGA ESCA -0.226; TCGA LGG -0.082; TCGA LIHC -0.093; TCGA LUAD -0.154; TCGA LUSC -0.251; TCGA STAD -0.109; TCGA UCEC -0.091 |
hsa-miR-128-3p | MCTP1 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUSC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.489; TCGA BRCA -0.452; TCGA COAD -0.656; TCGA ESCA -0.657; TCGA HNSC -0.166; TCGA KIRC -0.172; TCGA LUSC -0.628; TCGA STAD -0.302; TCGA UCEC -0.484 |
hsa-miR-128-3p | MID2 | 10 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LIHC; LUAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.275; TCGA BRCA -0.243; TCGA COAD -0.422; TCGA ESCA -0.375; TCGA KIRC -0.109; TCGA LIHC -0.194; TCGA LUAD -0.23; TCGA SARC -0.24; TCGA STAD -0.752; TCGA UCEC -0.37 |
hsa-miR-128-3p | NTRK3 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUAD; LUSC; OV; PRAD; STAD; UCEC | miRNAWalker2 validate; miRTarBase | TCGA BLCA -0.912; TCGA BRCA -0.579; TCGA CESC -0.504; TCGA COAD -1.334; TCGA ESCA -1.131; TCGA LUAD -0.96; TCGA LUSC -0.658; TCGA OV -0.447; TCGA PRAD -0.404; TCGA STAD -1.385; TCGA UCEC -0.591 |
hsa-miR-128-3p | PDE3A | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LUSC; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.592; TCGA BRCA -0.521; TCGA COAD -0.507; TCGA ESCA -0.99; TCGA KIRC -0.24; TCGA LUSC -0.414; TCGA SARC -0.367; TCGA STAD -0.885; TCGA UCEC -0.252 |
hsa-miR-128-3p | PDZRN4 | 13 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -1.515; TCGA BRCA -0.744; TCGA COAD -1.695; TCGA ESCA -1.472; TCGA KIRC -0.811; TCGA KIRP -0.317; TCGA LUAD -0.534; TCGA LUSC -0.69; TCGA PRAD -0.715; TCGA SARC -0.722; TCGA THCA -1.2; TCGA STAD -2.461; TCGA UCEC -0.763 |
hsa-miR-128-3p | PLA2G5 | 12 cancers: BLCA; BRCA; COAD; ESCA; LIHC; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -1.132; TCGA BRCA -0.343; TCGA COAD -1.073; TCGA ESCA -0.905; TCGA LIHC -0.277; TCGA LUAD -0.464; TCGA LUSC -0.908; TCGA OV -0.402; TCGA PRAD -0.31; TCGA THCA -0.393; TCGA STAD -1.022; TCGA UCEC -0.339 |
hsa-miR-128-3p | PTGS2 | 9 cancers: BLCA; BRCA; KIRC; LIHC; LUSC; PAAD; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.578; TCGA BRCA -0.42; TCGA KIRC -0.71; TCGA LIHC -0.566; TCGA LUSC -0.522; TCGA PAAD -0.898; TCGA PRAD -0.907; TCGA THCA -0.965; TCGA UCEC -0.411 |
hsa-miR-128-3p | RBM24 | 9 cancers: BLCA; BRCA; COAD; ESCA; LIHC; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.898; TCGA BRCA -0.41; TCGA COAD -0.757; TCGA ESCA -0.642; TCGA LIHC -0.318; TCGA PRAD -0.534; TCGA SARC -0.575; TCGA STAD -1.232; TCGA UCEC -0.686 |
hsa-miR-128-3p | SERTAD4 | 9 cancers: BLCA; BRCA; COAD; KIRC; LUAD; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.327; TCGA BRCA -0.166; TCGA COAD -0.742; TCGA KIRC -0.312; TCGA LUAD -0.475; TCGA PAAD -0.284; TCGA PRAD -0.298; TCGA STAD -0.999; TCGA UCEC -0.689 |
hsa-miR-128-3p | SH3BGRL | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.365; TCGA BRCA -0.279; TCGA CESC -0.268; TCGA COAD -0.46; TCGA ESCA -0.413; TCGA KIRC -0.097; TCGA LUAD -0.247; TCGA LUSC -0.381; TCGA OV -0.086; TCGA PRAD -0.149; TCGA SARC -0.388; TCGA STAD -0.783; TCGA UCEC -0.236 |
hsa-miR-128-3p | SH3D19 | 11 cancers: BLCA; BRCA; CESC; COAD; LIHC; LUAD; LUSC; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.332; TCGA BRCA -0.495; TCGA CESC -0.153; TCGA COAD -0.115; TCGA LIHC -0.21; TCGA LUAD -0.241; TCGA LUSC -0.233; TCGA PAAD -0.271; TCGA SARC -0.314; TCGA STAD -0.438; TCGA UCEC -0.247 |
hsa-miR-128-3p | SNRK | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.12; TCGA BRCA -0.253; TCGA CESC -0.123; TCGA COAD -0.159; TCGA ESCA -0.245; TCGA KIRC -0.121; TCGA LUAD -0.143; TCGA LUSC -0.196; TCGA STAD -0.288; TCGA UCEC -0.207 |
hsa-miR-128-3p | TAGLN | 18 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -1.167; TCGA BRCA -0.381; TCGA CESC -0.505; TCGA COAD -1.1; TCGA ESCA -0.994; TCGA KIRC -0.284; TCGA KIRP -0.38; TCGA LGG -0.179; TCGA LIHC -0.449; TCGA LUAD -0.325; TCGA LUSC -0.715; TCGA OV -0.308; TCGA PAAD -0.696; TCGA PRAD -0.575; TCGA SARC -1.514; TCGA THCA -0.259; TCGA STAD -1.61; TCGA UCEC -0.772 |
hsa-miR-128-3p | TGFBR1 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LGG; LUSC; THCA; STAD; UCEC | miRNAWalker2 validate; miRTarBase | TCGA BLCA -0.248; TCGA BRCA -0.157; TCGA CESC -0.219; TCGA COAD -0.242; TCGA ESCA -0.245; TCGA KIRC -0.126; TCGA LGG -0.21; TCGA LUSC -0.092; TCGA THCA -0.654; TCGA STAD -0.178; TCGA UCEC -0.077 |
hsa-miR-128-3p | TM4SF1 | 13 cancers: BLCA; CESC; COAD; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.367; TCGA CESC -0.412; TCGA COAD -0.253; TCGA HNSC -0.161; TCGA LGG -0.261; TCGA LIHC -0.263; TCGA LUAD -0.322; TCGA LUSC -0.211; TCGA OV -0.197; TCGA PAAD -0.987; TCGA PRAD -0.287; TCGA THCA -0.722; TCGA UCEC -0.303 |
hsa-miR-128-3p | TXNIP | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LUAD; LUSC; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate; MirTarget | TCGA BLCA -0.377; TCGA BRCA -0.474; TCGA CESC -0.337; TCGA COAD -0.493; TCGA ESCA -0.666; TCGA LGG -0.122; TCGA LUAD -0.569; TCGA LUSC -0.484; TCGA PAAD -0.332; TCGA SARC -0.202; TCGA STAD -0.933; TCGA UCEC -0.534 |
hsa-miR-128-3p | USP25 | 10 cancers: BLCA; BRCA; ESCA; KIRC; LUAD; LUSC; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.131; TCGA BRCA -0.145; TCGA ESCA -0.208; TCGA KIRC -0.122; TCGA LUAD -0.165; TCGA LUSC -0.172; TCGA SARC -0.162; TCGA THCA -0.101; TCGA STAD -0.15; TCGA UCEC -0.072 |
hsa-miR-128-3p | VEGFC | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LIHC; LUSC; STAD; UCEC | miRNAWalker2 validate; MirTarget | TCGA BLCA -0.377; TCGA BRCA -0.278; TCGA COAD -0.704; TCGA ESCA -0.546; TCGA HNSC -0.345; TCGA KIRP -0.211; TCGA LIHC -0.199; TCGA LUSC -0.589; TCGA STAD -0.362; TCGA UCEC -0.296 |
hsa-miR-128-3p | VPS13C | 9 cancers: BLCA; BRCA; ESCA; KIRC; LUAD; LUSC; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.158; TCGA BRCA -0.337; TCGA ESCA -0.255; TCGA KIRC -0.107; TCGA LUAD -0.202; TCGA LUSC -0.128; TCGA SARC -0.146; TCGA THCA -0.21; TCGA UCEC -0.208 |
hsa-miR-128-3p | VPS13D | 11 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.11; TCGA BRCA -0.256; TCGA CESC -0.152; TCGA ESCA -0.208; TCGA KIRC -0.186; TCGA LUAD -0.138; TCGA LUSC -0.077; TCGA PRAD -0.098; TCGA THCA -0.112; TCGA STAD -0.208; TCGA UCEC -0.087 |
hsa-miR-128-3p | WDR81 | 10 cancers: BLCA; CESC; COAD; LGG; LIHC; LUAD; LUSC; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.112; TCGA CESC -0.146; TCGA COAD -0.13; TCGA LGG -0.091; TCGA LIHC -0.096; TCGA LUAD -0.22; TCGA LUSC -0.075; TCGA PRAD -0.138; TCGA THCA -0.2; TCGA UCEC -0.167 |
hsa-miR-128-3p | YIPF5 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; STAD | miRNAWalker2 validate | TCGA BLCA -0.139; TCGA BRCA -0.122; TCGA COAD -0.127; TCGA ESCA -0.201; TCGA HNSC -0.069; TCGA LIHC -0.095; TCGA LUAD -0.058; TCGA LUSC -0.122; TCGA STAD -0.1 |
hsa-miR-128-3p | PRDM16 | 11 cancers: BLCA; BRCA; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.474; TCGA BRCA -0.448; TCGA KIRC -0.953; TCGA KIRP -0.761; TCGA LIHC -0.353; TCGA LUAD -0.928; TCGA LUSC -0.572; TCGA PAAD -0.437; TCGA SARC -0.607; TCGA STAD -0.349; TCGA UCEC -0.575 |
hsa-miR-128-3p | AFF3 | 9 cancers: BLCA; BRCA; COAD; ESCA; LUAD; LUSC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.878; TCGA BRCA -0.834; TCGA COAD -1.01; TCGA ESCA -0.767; TCGA LUAD -0.696; TCGA LUSC -0.649; TCGA THCA -0.39; TCGA STAD -1.355; TCGA UCEC -0.321 |
hsa-miR-128-3p | PDPN | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.724; TCGA BRCA -0.286; TCGA CESC -0.434; TCGA COAD -0.523; TCGA ESCA -0.365; TCGA HNSC -0.198; TCGA LGG -0.474; TCGA LIHC -0.529; TCGA LUSC -0.423; TCGA PAAD -0.907; TCGA PRAD -0.337; TCGA THCA -0.648; TCGA STAD -0.281; TCGA UCEC -0.272 |
hsa-miR-128-3p | NDST1 | 9 cancers: BLCA; BRCA; CESC; COAD; HNSC; LUAD; LUSC; THCA; STAD | MirTarget | TCGA BLCA -0.124; TCGA BRCA -0.236; TCGA CESC -0.221; TCGA COAD -0.204; TCGA HNSC -0.107; TCGA LUAD -0.215; TCGA LUSC -0.337; TCGA THCA -0.071; TCGA STAD -0.24 |
hsa-miR-128-3p | CLIC4 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LIHC; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.488; TCGA BRCA -0.13; TCGA CESC -0.114; TCGA COAD -0.532; TCGA ESCA -0.339; TCGA LGG -0.218; TCGA LIHC -0.122; TCGA LUSC -0.15; TCGA PAAD -0.288; TCGA PRAD -0.122; TCGA SARC -0.335; TCGA STAD -0.571; TCGA UCEC -0.156 |
hsa-miR-128-3p | ELMO1 | 9 cancers: BLCA; BRCA; CESC; COAD; KIRP; LUAD; LUSC; STAD; UCEC | MirTarget | TCGA BLCA -0.266; TCGA BRCA -0.096; TCGA CESC -0.272; TCGA COAD -0.544; TCGA KIRP -0.189; TCGA LUAD -0.297; TCGA LUSC -0.167; TCGA STAD -0.172; TCGA UCEC -0.208 |
hsa-miR-128-3p | LBH | 9 cancers: BLCA; BRCA; COAD; LGG; LIHC; LUAD; LUSC; STAD; UCEC | MirTarget | TCGA BLCA -0.24; TCGA BRCA -0.065; TCGA COAD -0.451; TCGA LGG -0.084; TCGA LIHC -0.207; TCGA LUAD -0.282; TCGA LUSC -0.293; TCGA STAD -0.162; TCGA UCEC -0.224 |
hsa-miR-128-3p | IL13RA1 | 11 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; THCA | MirTarget | TCGA BLCA -0.154; TCGA BRCA -0.166; TCGA ESCA -0.198; TCGA HNSC -0.1; TCGA KIRC -0.083; TCGA KIRP -0.076; TCGA LGG -0.15; TCGA LIHC -0.129; TCGA LUAD -0.079; TCGA LUSC -0.167; TCGA THCA -0.252 |
hsa-miR-128-3p | RAB20 | 9 cancers: BLCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD | MirTarget | TCGA BLCA -0.143; TCGA HNSC -0.152; TCGA LGG -0.23; TCGA LIHC -0.351; TCGA LUAD -0.206; TCGA LUSC -0.423; TCGA OV -0.121; TCGA PAAD -0.278; TCGA PRAD -0.198 |
hsa-miR-128-3p | THSD4 | 13 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.52; TCGA BRCA -0.799; TCGA ESCA -0.633; TCGA KIRC -0.632; TCGA KIRP -0.326; TCGA LIHC -0.284; TCGA LUAD -0.296; TCGA LUSC -0.311; TCGA PAAD -0.264; TCGA PRAD -0.391; TCGA SARC -0.426; TCGA THCA -0.287; TCGA STAD -0.812 |
hsa-miR-128-3p | ARHGEF37 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.638; TCGA BRCA -0.417; TCGA CESC -0.435; TCGA COAD -0.413; TCGA ESCA -0.502; TCGA HNSC -0.427; TCGA LUAD -0.386; TCGA LUSC -0.374; TCGA PRAD -0.122; TCGA SARC -0.525; TCGA STAD -0.811; TCGA UCEC -0.268 |
hsa-miR-128-3p | RIC3 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.642; TCGA BRCA -0.463; TCGA CESC -0.301; TCGA COAD -1.399; TCGA ESCA -0.744; TCGA KIRC -0.701; TCGA LUAD -0.809; TCGA LUSC -0.359; TCGA PRAD -0.356; TCGA STAD -1.404; TCGA UCEC -0.746 |
hsa-miR-128-3p | CSF1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LUAD; LUSC; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.508; TCGA BRCA -0.194; TCGA CESC -0.265; TCGA COAD -0.26; TCGA ESCA -0.293; TCGA LGG -0.134; TCGA LUAD -0.189; TCGA LUSC -0.524; TCGA SARC -0.245; TCGA THCA -0.525; TCGA STAD -0.212; TCGA UCEC -0.183 |
hsa-miR-128-3p | MAP3K8 | 11 cancers: BLCA; BRCA; CESC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; UCEC | MirTarget | TCGA BLCA -0.209; TCGA BRCA -0.157; TCGA CESC -0.215; TCGA LGG -0.136; TCGA LIHC -0.352; TCGA LUAD -0.19; TCGA LUSC -0.446; TCGA PAAD -0.354; TCGA PRAD -0.234; TCGA SARC -0.476; TCGA UCEC -0.196 |
hsa-miR-128-3p | PLK2 | 9 cancers: BLCA; BRCA; CESC; HNSC; LIHC; LUAD; LUSC; OV; UCEC | MirTarget | TCGA BLCA -0.354; TCGA BRCA -0.293; TCGA CESC -0.449; TCGA HNSC -0.343; TCGA LIHC -0.235; TCGA LUAD -0.159; TCGA LUSC -0.416; TCGA OV -0.217; TCGA UCEC -0.142 |
hsa-miR-128-3p | ZEB1 | 9 cancers: BLCA; BRCA; COAD; ESCA; LUAD; LUSC; OV; STAD; UCEC | MirTarget | TCGA BLCA -0.688; TCGA BRCA -0.439; TCGA COAD -0.859; TCGA ESCA -0.684; TCGA LUAD -0.303; TCGA LUSC -0.453; TCGA OV -0.148; TCGA STAD -0.867; TCGA UCEC -0.567 |
hsa-miR-128-3p | PRKAG2 | 10 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LIHC; LUSC; SARC; STAD | MirTarget | TCGA BLCA -0.341; TCGA BRCA -0.098; TCGA COAD -0.11; TCGA ESCA -0.247; TCGA KIRC -0.156; TCGA KIRP -0.106; TCGA LIHC -0.169; TCGA LUSC -0.166; TCGA SARC -0.563; TCGA STAD -0.414 |
hsa-miR-128-3p | COL3A1 | 11 cancers: BLCA; CESC; COAD; ESCA; KIRP; LGG; LIHC; LUSC; PAAD; THCA; UCEC | MirTarget | TCGA BLCA -0.822; TCGA CESC -0.358; TCGA COAD -0.613; TCGA ESCA -0.5; TCGA KIRP -0.304; TCGA LGG -0.702; TCGA LIHC -0.437; TCGA LUSC -0.414; TCGA PAAD -0.944; TCGA THCA -0.843; TCGA UCEC -0.373 |
hsa-miR-128-3p | ROR1 | 9 cancers: BLCA; BRCA; COAD; ESCA; LUAD; LUSC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.751; TCGA BRCA -0.392; TCGA COAD -0.666; TCGA ESCA -0.561; TCGA LUAD -0.306; TCGA LUSC -0.827; TCGA THCA -1.278; TCGA STAD -0.665; TCGA UCEC -0.352 |
hsa-miR-128-3p | G0S2 | 9 cancers: BLCA; BRCA; KIRP; LUSC; OV; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.543; TCGA BRCA -0.386; TCGA KIRP -0.352; TCGA LUSC -0.634; TCGA OV -0.246; TCGA PAAD -0.73; TCGA PRAD -0.253; TCGA THCA -0.925; TCGA UCEC -0.286 |
hsa-miR-128-3p | APLNR | 9 cancers: BLCA; BRCA; CESC; COAD; LIHC; LUAD; LUSC; THCA; UCEC | MirTarget | TCGA BLCA -0.378; TCGA BRCA -0.166; TCGA CESC -0.215; TCGA COAD -0.501; TCGA LIHC -0.269; TCGA LUAD -0.344; TCGA LUSC -0.516; TCGA THCA -0.291; TCGA UCEC -0.243 |
hsa-miR-128-3p | DOCK11 | 10 cancers: BLCA; BRCA; COAD; ESCA; LGG; LUAD; LUSC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.553; TCGA BRCA -0.311; TCGA COAD -0.306; TCGA ESCA -0.419; TCGA LGG -0.176; TCGA LUAD -0.177; TCGA LUSC -0.448; TCGA THCA -0.31; TCGA STAD -0.397; TCGA UCEC -0.154 |
hsa-miR-128-3p | GRIA3 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.686; TCGA BRCA -0.251; TCGA CESC -0.288; TCGA ESCA -0.703; TCGA HNSC -0.216; TCGA LUSC -0.435; TCGA PRAD -0.514; TCGA SARC -0.605; TCGA STAD -0.917; TCGA UCEC -0.676 |
hsa-miR-128-3p | ENPP6 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LUAD; LUSC; PRAD; STAD | MirTarget | TCGA BLCA -0.541; TCGA BRCA -0.198; TCGA CESC -0.398; TCGA COAD -0.475; TCGA ESCA -0.412; TCGA KIRP -0.455; TCGA LUAD -0.32; TCGA LUSC -0.401; TCGA PRAD -0.587; TCGA STAD -0.974 |
hsa-miR-128-3p | CTDSP2 | 12 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; LGG; LUAD; LUSC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.177; TCGA BRCA -0.219; TCGA CESC -0.099; TCGA COAD -0.165; TCGA KIRC -0.12; TCGA KIRP -0.136; TCGA LGG -0.128; TCGA LUAD -0.123; TCGA LUSC -0.072; TCGA THCA -0.077; TCGA STAD -0.137; TCGA UCEC -0.107 |
hsa-miR-128-3p | MSRB3 | 14 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.996; TCGA BRCA -0.609; TCGA COAD -1.101; TCGA ESCA -0.814; TCGA KIRC -0.15; TCGA LIHC -0.173; TCGA LUAD -0.427; TCGA LUSC -0.565; TCGA OV -0.232; TCGA PAAD -0.414; TCGA PRAD -0.378; TCGA SARC -0.603; TCGA STAD -1.206; TCGA UCEC -0.657 |
hsa-miR-128-3p | TNFAIP8 | 11 cancers: BLCA; CESC; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; SARC; STAD | MirTarget | TCGA BLCA -0.206; TCGA CESC -0.267; TCGA ESCA -0.204; TCGA HNSC -0.224; TCGA LGG -0.414; TCGA LIHC -0.144; TCGA LUAD -0.137; TCGA LUSC -0.198; TCGA PAAD -0.501; TCGA SARC -0.195; TCGA STAD -0.456 |
hsa-miR-128-3p | SGMS1 | 10 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LUAD; LUSC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.151; TCGA BRCA -0.136; TCGA CESC -0.105; TCGA ESCA -0.164; TCGA KIRC -0.197; TCGA LUAD -0.203; TCGA LUSC -0.183; TCGA THCA -0.294; TCGA STAD -0.093; TCGA UCEC -0.088 |
hsa-miR-128-3p | SLC39A13 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.153; TCGA CESC -0.127; TCGA COAD -0.179; TCGA ESCA -0.174; TCGA HNSC -0.103; TCGA LGG -0.062; TCGA LUAD -0.248; TCGA LUSC -0.276; TCGA PAAD -0.146; TCGA SARC -0.162; TCGA THCA -0.119; TCGA STAD -0.188; TCGA UCEC -0.085 |
hsa-miR-128-3p | PQLC3 | 14 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.25; TCGA BRCA -0.155; TCGA COAD -0.208; TCGA ESCA -0.202; TCGA KIRC -0.134; TCGA KIRP -0.147; TCGA LGG -0.167; TCGA LUAD -0.181; TCGA LUSC -0.19; TCGA PAAD -0.43; TCGA SARC -0.142; TCGA THCA -0.087; TCGA STAD -0.245; TCGA UCEC -0.177 |
hsa-miR-128-3p | NFIL3 | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LGG; LUSC; SARC; STAD | MirTarget | TCGA BLCA -0.35; TCGA CESC -0.202; TCGA ESCA -0.224; TCGA HNSC -0.148; TCGA KIRP -0.163; TCGA LGG -0.17; TCGA LUSC -0.157; TCGA SARC -0.174; TCGA STAD -0.14 |
hsa-miR-128-3p | CCDC50 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LUSC; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.145; TCGA BRCA -0.199; TCGA CESC -0.169; TCGA COAD -0.19; TCGA ESCA -0.128; TCGA LGG -0.067; TCGA LUSC -0.135; TCGA PAAD -0.141; TCGA SARC -0.159; TCGA STAD -0.354; TCGA UCEC -0.089 |
hsa-miR-128-3p | PRKD1 | 11 cancers: BLCA; BRCA; COAD; ESCA; LGG; LUSC; OV; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.408; TCGA BRCA -0.462; TCGA COAD -1.086; TCGA ESCA -0.451; TCGA LGG -0.123; TCGA LUSC -0.151; TCGA OV -0.182; TCGA PRAD -0.164; TCGA SARC -0.334; TCGA STAD -0.75; TCGA UCEC -0.236 |
hsa-miR-128-3p | LGALS3 | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.26; TCGA BRCA -0.283; TCGA CESC -0.147; TCGA ESCA -0.28; TCGA HNSC -0.191; TCGA LIHC -0.312; TCGA LUAD -0.238; TCGA LUSC -0.346; TCGA OV -0.293; TCGA PAAD -0.977; TCGA PRAD -0.375; TCGA SARC -0.331; TCGA THCA -0.963; TCGA UCEC -0.201 |
hsa-miR-128-3p | ATL3 | 9 cancers: BLCA; ESCA; HNSC; KIRC; LGG; LUSC; PAAD; SARC; STAD | MirTarget | TCGA BLCA -0.211; TCGA ESCA -0.171; TCGA HNSC -0.145; TCGA KIRC -0.172; TCGA LGG -0.085; TCGA LUSC -0.191; TCGA PAAD -0.38; TCGA SARC -0.175; TCGA STAD -0.134 |
hsa-miR-128-3p | IRS1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.231; TCGA BRCA -0.516; TCGA CESC -0.215; TCGA COAD -0.31; TCGA ESCA -0.302; TCGA KIRC -0.394; TCGA LUSC -0.202; TCGA PAAD -0.369; TCGA PRAD -0.214; TCGA SARC -0.212; TCGA STAD -0.294; TCGA UCEC -0.411 |
hsa-miR-128-3p | RASL12 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.744; TCGA BRCA -0.208; TCGA CESC -0.254; TCGA COAD -0.646; TCGA ESCA -0.626; TCGA LUAD -0.443; TCGA LUSC -0.614; TCGA PRAD -0.49; TCGA SARC -0.989; TCGA STAD -0.752; TCGA UCEC -0.68 |
hsa-miR-128-3p | GAPT | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.676; TCGA BRCA -0.138; TCGA CESC -0.331; TCGA COAD -0.733; TCGA ESCA -0.74; TCGA LGG -0.377; TCGA LIHC -0.286; TCGA LUAD -0.526; TCGA LUSC -0.695; TCGA PAAD -0.376; TCGA SARC -0.364; TCGA THCA -0.371; TCGA STAD -0.76; TCGA UCEC -0.339 |
hsa-miR-128-3p | FAM155A | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LIHC; LUSC; OV; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.434; TCGA BRCA -0.265; TCGA COAD -0.708; TCGA ESCA -0.335; TCGA KIRP -0.455; TCGA LIHC -0.223; TCGA LUSC -0.594; TCGA OV -0.357; TCGA PRAD -0.252; TCGA STAD -0.331; TCGA UCEC -0.613 |
hsa-miR-128-3p | FAT2 | 9 cancers: BLCA; BRCA; CESC; HNSC; LUAD; PAAD; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.349; TCGA BRCA -0.697; TCGA CESC -0.495; TCGA HNSC -0.197; TCGA LUAD -0.387; TCGA PAAD -0.518; TCGA PRAD -0.584; TCGA THCA -0.596; TCGA STAD -0.423 |
hsa-miR-128-3p | MGLL | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.545; TCGA BRCA -0.373; TCGA CESC -0.261; TCGA COAD -0.222; TCGA ESCA -0.296; TCGA KIRP -0.354; TCGA LUAD -0.747; TCGA LUSC -0.544; TCGA PAAD -0.522; TCGA PRAD -0.348; TCGA SARC -0.21; TCGA THCA -0.198; TCGA STAD -0.719; TCGA UCEC -0.372 |
hsa-miR-128-3p | SAMD9L | 9 cancers: BLCA; CESC; ESCA; LGG; LUAD; LUSC; PAAD; SARC; THCA | MirTarget | TCGA BLCA -0.387; TCGA CESC -0.339; TCGA ESCA -0.403; TCGA LGG -0.246; TCGA LUAD -0.143; TCGA LUSC -0.553; TCGA PAAD -0.583; TCGA SARC -0.213; TCGA THCA -0.206 |
hsa-miR-128-3p | FBLN2 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.815; TCGA BRCA -0.274; TCGA CESC -0.333; TCGA COAD -0.777; TCGA ESCA -0.762; TCGA LIHC -0.392; TCGA LUAD -0.165; TCGA LUSC -0.536; TCGA PAAD -0.553; TCGA THCA -0.47; TCGA STAD -0.589; TCGA UCEC -0.189 |
hsa-miR-128-3p | BTG2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LGG; LIHC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.193; TCGA BRCA -0.462; TCGA CESC -0.175; TCGA COAD -0.154; TCGA ESCA -0.267; TCGA KIRC -0.298; TCGA LGG -0.074; TCGA LIHC -0.22; TCGA LUAD -0.569; TCGA LUSC -0.299; TCGA PRAD -0.357; TCGA SARC -0.216; TCGA STAD -0.641; TCGA UCEC -0.307 |
hsa-miR-128-3p | KIT | 13 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.254; TCGA BRCA -0.716; TCGA COAD -0.597; TCGA ESCA -0.875; TCGA KIRC -0.626; TCGA KIRP -0.316; TCGA LIHC -0.342; TCGA LUAD -0.298; TCGA LUSC -0.254; TCGA OV -0.363; TCGA PRAD -0.19; TCGA STAD -1.075; TCGA UCEC -0.325 |
hsa-miR-128-3p | IFFO2 | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; UCEC | MirTarget | TCGA BLCA -0.209; TCGA BRCA -0.145; TCGA CESC -0.357; TCGA HNSC -0.372; TCGA KIRP -0.151; TCGA LUAD -0.323; TCGA LUSC -0.31; TCGA PAAD -0.329; TCGA PRAD -0.209; TCGA UCEC -0.148 |
hsa-miR-128-3p | HIC1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.611; TCGA BRCA -0.19; TCGA CESC -0.28; TCGA COAD -0.514; TCGA ESCA -0.493; TCGA KIRP -0.279; TCGA LGG -0.22; TCGA LIHC -0.297; TCGA LUAD -0.16; TCGA LUSC -0.509; TCGA OV -0.2; TCGA PAAD -0.377; TCGA STAD -0.48; TCGA UCEC -0.677 |
hsa-miR-128-3p | F3 | 13 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.633; TCGA BRCA -0.533; TCGA ESCA -0.266; TCGA HNSC -0.279; TCGA KIRC -0.581; TCGA KIRP -0.281; TCGA LIHC -0.298; TCGA LUAD -0.314; TCGA LUSC -0.373; TCGA PAAD -0.673; TCGA PRAD -0.64; TCGA STAD -0.199; TCGA UCEC -0.24 |
hsa-miR-128-3p | NAP1L5 | 11 cancers: BLCA; BRCA; COAD; KIRC; LIHC; LUAD; LUSC; OV; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.255; TCGA BRCA -0.241; TCGA COAD -0.2; TCGA KIRC -0.12; TCGA LIHC -0.164; TCGA LUAD -0.124; TCGA LUSC -0.166; TCGA OV -0.237; TCGA PRAD -0.2; TCGA STAD -0.618; TCGA UCEC -0.292 |
hsa-miR-128-3p | LRRN4CL | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.883; TCGA BRCA -0.887; TCGA CESC -0.575; TCGA COAD -0.906; TCGA ESCA -0.604; TCGA LGG -0.451; TCGA LUAD -0.616; TCGA LUSC -0.545; TCGA OV -0.429; TCGA PAAD -0.759; TCGA PRAD -0.223; TCGA STAD -1.167; TCGA UCEC -0.842 |
hsa-miR-128-3p | PHC2 | 11 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.107; TCGA CESC -0.105; TCGA ESCA -0.101; TCGA HNSC -0.077; TCGA KIRP -0.121; TCGA LGG -0.155; TCGA LUAD -0.066; TCGA LUSC -0.261; TCGA PRAD -0.059; TCGA THCA -0.056; TCGA STAD -0.099 |
hsa-miR-128-3p | SMARCA2 | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LUAD; OV; STAD; UCEC | MirTarget | TCGA BLCA -0.186; TCGA BRCA -0.224; TCGA COAD -0.156; TCGA ESCA -0.204; TCGA KIRC -0.115; TCGA LUAD -0.325; TCGA OV -0.214; TCGA STAD -0.37; TCGA UCEC -0.293 |
hsa-miR-128-3p | TEAD1 | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.261; TCGA BRCA -0.341; TCGA COAD -0.267; TCGA ESCA -0.175; TCGA KIRC -0.103; TCGA SARC -0.128; TCGA THCA -0.22; TCGA STAD -0.394; TCGA UCEC -0.101 |
hsa-miR-128-3p | MEGF6 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; THCA | MirTarget | TCGA BLCA -0.295; TCGA BRCA -0.131; TCGA CESC -0.24; TCGA COAD -0.318; TCGA ESCA -0.339; TCGA LIHC -0.882; TCGA LUAD -0.643; TCGA LUSC -0.505; TCGA PAAD -0.837; TCGA THCA -0.369 |
hsa-miR-128-3p | ARRDC4 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; STAD; UCEC | MirTarget | TCGA BLCA -0.347; TCGA BRCA -0.328; TCGA CESC -0.273; TCGA COAD -0.239; TCGA ESCA -0.528; TCGA HNSC -0.322; TCGA KIRC -0.135; TCGA LGG -0.154; TCGA LUAD -0.513; TCGA LUSC -0.282; TCGA STAD -0.605; TCGA UCEC -0.336 |
hsa-miR-128-3p | FAM177A1 | 9 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LIHC; LUSC; PRAD; SARC | MirTarget | TCGA BLCA -0.131; TCGA COAD -0.137; TCGA ESCA -0.221; TCGA HNSC -0.125; TCGA KIRC -0.077; TCGA LIHC -0.109; TCGA LUSC -0.21; TCGA PRAD -0.075; TCGA SARC -0.132 |
hsa-miR-128-3p | SH2D3C | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LIHC; LUAD; LUSC; STAD; UCEC | MirTarget | TCGA BLCA -0.216; TCGA BRCA -0.1; TCGA CESC -0.251; TCGA COAD -0.335; TCGA ESCA -0.22; TCGA KIRP -0.35; TCGA LIHC -0.124; TCGA LUAD -0.394; TCGA LUSC -0.548; TCGA STAD -0.316; TCGA UCEC -0.436 |
hsa-miR-128-3p | GREM1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LIHC; LUSC; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -1.134; TCGA BRCA -0.16; TCGA CESC -0.484; TCGA COAD -1.163; TCGA ESCA -1.252; TCGA KIRC -1.133; TCGA LIHC -0.504; TCGA LUSC -0.285; TCGA PAAD -1.295; TCGA SARC -1.137; TCGA THCA -1.154; TCGA STAD -0.976; TCGA UCEC -0.349 |
hsa-miR-128-3p | LTBP1 | 11 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LGG; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.412; TCGA COAD -0.687; TCGA ESCA -0.57; TCGA KIRC -0.524; TCGA KIRP -0.256; TCGA LGG -0.148; TCGA PAAD -0.602; TCGA SARC -0.276; TCGA THCA -0.447; TCGA STAD -0.804; TCGA UCEC -0.143 |
hsa-miR-128-3p | ARL15 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; STAD; UCEC | MirTarget | TCGA BLCA -0.238; TCGA BRCA -0.434; TCGA CESC -0.18; TCGA COAD -0.156; TCGA ESCA -0.349; TCGA KIRC -0.15; TCGA KIRP -0.146; TCGA LUAD -0.105; TCGA STAD -0.089; TCGA UCEC -0.28 |
hsa-miR-128-3p | ISLR | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -1.115; TCGA BRCA -0.181; TCGA CESC -0.389; TCGA COAD -0.849; TCGA ESCA -0.729; TCGA KIRC -0.597; TCGA KIRP -0.375; TCGA LIHC -0.795; TCGA LUAD -0.359; TCGA LUSC -0.584; TCGA OV -0.272; TCGA PAAD -0.755; TCGA PRAD -0.189; TCGA THCA -0.482; TCGA STAD -0.678; TCGA UCEC -0.554 |
hsa-miR-128-3p | SYNM | 9 cancers: BLCA; BRCA; COAD; ESCA; LUAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -1.322; TCGA BRCA -0.55; TCGA COAD -1.523; TCGA ESCA -0.939; TCGA LUAD -0.204; TCGA PRAD -0.728; TCGA SARC -0.821; TCGA STAD -2.081; TCGA UCEC -0.481 |
hsa-miR-128-3p | TYRP1 | 9 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; STAD | MirTarget | TCGA BLCA -0.627; TCGA COAD -0.87; TCGA ESCA -0.976; TCGA KIRC -1.317; TCGA KIRP -0.683; TCGA LUAD -0.586; TCGA LUSC -0.335; TCGA PAAD -0.583; TCGA STAD -1.217 |
hsa-miR-128-3p | PPP2R3A | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LUAD; PAAD; THCA; STAD | MirTarget | TCGA BLCA -0.132; TCGA BRCA -0.108; TCGA COAD -0.355; TCGA ESCA -0.29; TCGA KIRC -0.149; TCGA LUAD -0.168; TCGA PAAD -0.243; TCGA THCA -0.25; TCGA STAD -0.867 |
hsa-miR-128-3p | ACSL5 | 11 cancers: BRCA; CESC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.201; TCGA CESC -0.449; TCGA KIRP -0.414; TCGA LIHC -0.294; TCGA LUAD -0.658; TCGA LUSC -0.86; TCGA PAAD -1.045; TCGA PRAD -0.344; TCGA SARC -0.439; TCGA THCA -0.516; TCGA UCEC -0.396 |
hsa-miR-128-3p | ANKFY1 | 9 cancers: BRCA; CESC; ESCA; LGG; LIHC; LUAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.148; TCGA CESC -0.082; TCGA ESCA -0.097; TCGA LGG -0.055; TCGA LIHC -0.097; TCGA LUAD -0.118; TCGA THCA -0.211; TCGA STAD -0.081; TCGA UCEC -0.056 |
hsa-miR-128-3p | FAM89A | 10 cancers: BRCA; HNSC; KIRC; KIRP; LGG; LIHC; OV; PAAD; PRAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.19; TCGA HNSC -0.204; TCGA KIRC -0.209; TCGA KIRP -0.192; TCGA LGG -0.077; TCGA LIHC -0.329; TCGA OV -0.22; TCGA PAAD -0.203; TCGA PRAD -0.212; TCGA UCEC -0.227 |
hsa-miR-128-3p | GLTSCR2 | 12 cancers: BRCA; CESC; HNSC; KIRP; LGG; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.119; TCGA CESC -0.14; TCGA HNSC -0.076; TCGA KIRP -0.113; TCGA LGG -0.125; TCGA LUAD -0.203; TCGA LUSC -0.139; TCGA OV -0.237; TCGA PRAD -0.148; TCGA THCA -0.087; TCGA STAD -0.249; TCGA UCEC -0.155 |
hsa-miR-128-3p | KCTD14 | 9 cancers: BRCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.381; TCGA HNSC -0.284; TCGA LGG -0.129; TCGA LUAD -0.373; TCGA LUSC -0.41; TCGA PAAD -0.933; TCGA PRAD -0.459; TCGA SARC -0.219; TCGA THCA -0.122 |
hsa-miR-128-3p | RNF144B | 12 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; STAD | miRNAWalker2 validate | TCGA BRCA -0.221; TCGA COAD -0.239; TCGA ESCA -0.211; TCGA HNSC -0.122; TCGA KIRC -0.228; TCGA KIRP -0.241; TCGA LGG -0.068; TCGA LUAD -0.21; TCGA LUSC -0.22; TCGA PRAD -0.138; TCGA SARC -0.233; TCGA STAD -0.276 |
hsa-miR-128-3p | SUMF1 | 9 cancers: BRCA; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; SARC; STAD | miRNAWalker2 validate | TCGA BRCA -0.154; TCGA ESCA -0.133; TCGA HNSC -0.124; TCGA KIRC -0.171; TCGA LGG -0.12; TCGA LUAD -0.098; TCGA LUSC -0.151; TCGA SARC -0.108; TCGA STAD -0.1 |
hsa-miR-128-3p | MME | 9 cancers: BRCA; CESC; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BRCA -0.824; TCGA CESC -0.586; TCGA LIHC -0.586; TCGA LUAD -0.245; TCGA LUSC -0.662; TCGA PAAD -0.411; TCGA PRAD -0.334; TCGA THCA -0.608; TCGA UCEC -0.511 |
hsa-miR-128-3p | PDE8B | 10 cancers: BRCA; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA BRCA -0.749; TCGA COAD -0.418; TCGA ESCA -0.306; TCGA KIRC -0.657; TCGA LIHC -0.271; TCGA LUAD -0.255; TCGA LUSC -0.282; TCGA PRAD -0.384; TCGA STAD -0.793; TCGA UCEC -0.79 |
hsa-miR-128-3p | ARHGAP23 | 12 cancers: BRCA; CESC; COAD; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.225; TCGA CESC -0.436; TCGA COAD -0.338; TCGA LIHC -0.183; TCGA LUAD -0.322; TCGA LUSC -0.108; TCGA OV -0.208; TCGA PAAD -0.374; TCGA PRAD -0.302; TCGA THCA -0.555; TCGA STAD -0.392; TCGA UCEC -0.264 |
hsa-miR-128-3p | EMP2 | 9 cancers: BRCA; CESC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.168; TCGA CESC -0.18; TCGA LUAD -0.558; TCGA LUSC -0.33; TCGA PAAD -0.272; TCGA PRAD -0.159; TCGA THCA -0.458; TCGA STAD -0.235; TCGA UCEC -0.127 |
hsa-miR-128-3p | SLU7 | 10 cancers: BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; OV; SARC; STAD | MirTarget | TCGA BRCA -0.15; TCGA CESC -0.105; TCGA COAD -0.083; TCGA ESCA -0.115; TCGA LIHC -0.099; TCGA LUAD -0.142; TCGA LUSC -0.095; TCGA OV -0.084; TCGA SARC -0.068; TCGA STAD -0.096 |
hsa-miR-128-3p | ARL8B | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; SARC; THCA; STAD | MirTarget | TCGA BRCA -0.081; TCGA CESC -0.161; TCGA COAD -0.071; TCGA ESCA -0.112; TCGA HNSC -0.124; TCGA KIRC -0.171; TCGA LUAD -0.08; TCGA LUSC -0.082; TCGA SARC -0.163; TCGA THCA -0.145; TCGA STAD -0.111 |
hsa-miR-128-3p | YPEL3 | 10 cancers: BRCA; CESC; COAD; LIHC; LUAD; LUSC; OV; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.085; TCGA CESC -0.239; TCGA COAD -0.448; TCGA LIHC -0.122; TCGA LUAD -0.279; TCGA LUSC -0.201; TCGA OV -0.162; TCGA SARC -0.237; TCGA STAD -0.368; TCGA UCEC -0.228 |
hsa-miR-128-3p | C2CD2 | 10 cancers: BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; SARC; STAD | MirTarget | TCGA BRCA -0.226; TCGA CESC -0.177; TCGA ESCA -0.148; TCGA HNSC -0.173; TCGA LIHC -0.121; TCGA LUAD -0.077; TCGA LUSC -0.12; TCGA PAAD -0.266; TCGA SARC -0.198; TCGA STAD -0.209 |
hsa-miR-128-3p | TBC1D1 | 11 cancers: COAD; KIRC; KIRP; LGG; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA COAD -0.166; TCGA KIRC -0.217; TCGA KIRP -0.143; TCGA LGG -0.084; TCGA LUSC -0.152; TCGA PAAD -0.202; TCGA PRAD -0.229; TCGA SARC -0.318; TCGA THCA -0.083; TCGA STAD -0.294; TCGA UCEC -0.193 |
hsa-miR-128-3p | ANXA4 | 9 cancers: HNSC; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA; UCEC | MirTarget | TCGA HNSC -0.065; TCGA LGG -0.073; TCGA LIHC -0.166; TCGA LUAD -0.154; TCGA LUSC -0.152; TCGA PAAD -0.77; TCGA SARC -0.181; TCGA THCA -0.109; TCGA UCEC -0.117 |
Enriched cancer pathways of putative targets